COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 2347: Articles 23461-23470  | Next

Effects of SARS-CoV-2 Mutations on Protein Structures and Intraviral Protein-Protein Interactions
Wu, S., Tian, C., Liu, P., Guo, D., Zheng, W., Huang, X., Zhang, Y., Liu, L.
10.1101/2020.08.15.241349 — Posted: 2020-08-16
High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization.
Noval, M. G., Kaczmarek, M. E., Koide, A., Rodriguez-Rodriguez, B. A., Louie, P., Tada, T., Hattori, T., Panchenko, T., Romero, L. A., Teng, K. W., Bazley, A., de Vries, M., Samanovic, M. I., Weiser, J. N., Aifantis, I., Cangiarella, J., Mulligan, M. J., Desvignes, L., Dittmann, M., Landau, N. R., Aguero-Rosenfeld, M. E., Koide, S., Stapleford, K. A.
10.1101/2020.08.15.252353 — Posted: 2020-08-16
Susceptibility of swine cells and domestic pigs to SARS-CoV-2
Meekins, D. A., Morozov, I., Trujillo, J. D., Gaudreault, N. N., Bold, D., Artiaga, B. L., Indran, S. V., Kwon, T., Balaraman, V., Madden, D. W., Feldmann, H., Henningson, J., Ma, W., Balasuriya, U. B. R., Richt, J. A.
10.1101/2020.08.15.252395 — Posted: 2020-08-16 Discussion: Offsite
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model
Kreye, J., Reincke, S. M., Kornau, H.-C., Sanchez-Sendin, E., Corman, V. M., Liu, H., Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C. D., Trimpert, J., Hoeltje, M., Dietert, K., Stoeffler, L., von Wardenburg, N., van Hoof, S., Homeyer, M. A., Hoffmann, J., Abdelgawad, A., Gruber, A. D., Bertzbach, L. D., Vladimirova, D., Li, L. Y., Barthel, P. C., Skriner, K., Hocke, A. C., Hippenstiel, S., Witzenrath, M., Suttorp, N., Kurth, F., Franke, C., Endres, M., Schmitz, D., Jeworowski, L. M., Richter, A., Schmidt, M. L., Schwarz, T., Mueller, M. A., Drosten, C., Wendisch, D., Sander, L. E., Osterrieder, N., Wilson, I. A., Pruess, H.
10.1101/2020.08.15.252320 — Posted: 2020-08-16 Discussion: Onsite | Offsite
Sampling SARS-CoV-2 proteomes for predicted CD8 T-cell epitopes as a tool for understanding immunogenic breadth and rationale vaccine design
Hare, J., Morrison, D., Nielsen, M.
10.1101/2020.08.15.250647 — Posted: 2020-08-16
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
Malladi, S. K., Singh, R., Pandey, S., Gayathri, S., Kanjo, K., Ahmed, S., Khan, M. S., Kalita, P., Girish, N., Upadhyaya, A., Reddy, P., Pramanick, I., Bhasin, M., Mani, S., Bhattacharyya, S., Joseph, J., Thankamani, K., Raj, V. S., Dutta, S., Singh, R., Nadig, G., Varadarajan, R.
10.1101/2020.08.15.252437 — Posted: 2020-08-16
The limits of estimating COVID-19 intervention effects using Bayesian models
Bryant, P., Elofsson, A.
10.1101/2020.08.14.20175240 — Posted: 2020-08-16
Robust, reproducible clinical patterns in hospitalised patients with COVID-19
Millar, J. E., Neyton, L., Seth, S., Dunning, J., Merson, L., Murthy, S., Russell, C. D., Keating, S., Swets, M., Sudre, C. H., Spector, T. D., Ourselin, S., Steves, C. J., Wolf, J., ISARIC4C Investigators, , Docherty, A. B., Harrison, E. M., Openshaw, P. J., Semple, M. G., Baillie, J. K.
10.1101/2020.08.14.20168088 — Posted: 2020-08-16
Widespread testing, case isolation and contact tracing may allow safe school reopening with continued moderate physical distancing: a modeling analysis of King County, WA data
Bracis, C., Burns, E., Moore, M., Swan, D., Reeves, D. B., Schiffer, J. T., Dimitrov, D. T.
10.1101/2020.08.14.20174649 — Posted: 2020-08-16
Knowledge, Practice and associated factors towards the Prevention of COVID-19 among high-risk groups: A cross-sectional study in Addis Ababa, Ethiopia
DEFAR, A., Molla, G., Abdella, S., Tessema, M., Ahmed, M., Tadele, A., Getachew, F., Hailegiorgis, B., Tigabu, E., Ababor, S., Bizuwork, K., Deressa, A., Tasew, G., kebede, A., Melese, D., Gashu, A., Eshetu, K., Tayachew, A., Wossen, M., Hassen, A., Habebe, S., Assefa, Z., Abayneh, A., Abate, E., Tollera, G.
10.1101/2020.08.14.20172429 — Posted: 2020-08-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).